A systematic review of barriers to mammography screening and timely breast cancer diagnosis and treatment initiation: estimating the global impact.

IMPORTANCE: Breast cancer (BC) is the most commonly diagnosed cancer among women and a leading cause of cancer mortality worldwide. Understanding and addressing the barriers women face in accessing BC care is crucial for improving clinical outcomes and public health. OBJECTIVE: This paper describes and discusses the findings from a systematic literature review (SLR) of the barriers that women worldwide face in accessing mammography screening and diagnosis, which may lead to delays in BC treatment. We also aimed to estimate the number of women worldwide affected by delayed or absent. We also aimed to estimate the number of women affected by delayed or absent access to medical services. EVIDENCE REVIEW: The systematic literature review included a comprehensive search in bibliographic databases and grey literature. A total of 20,434 citations were identified, with 2,611 citations eligible for full-text examination, which resulted in 256 extracted sources fulfilling the inclusion criteria. We focused on quantitative data on the number of patients whose access to BC-related medical services was hindered by such barriers. FINDINGS: The review identified education, age, and geographic region as important factors influencing barriers to mammography. Educational level, residential location, and travel time showed the strongest associations with delay in BC diagnosis. Socio-demographic characteristics also had an impact on the stage of cancer at diagnosis. An estimated 869.8 million women are aged 50-75 years worldwide. Of these, approximately 679.7 million women (78%) do not receive mammography because either their country has no established mammography program (557.7 million) or because existing programs have low uptake rates for various reasons (122.1 million). Of the 2.3 million new BC cases annually worldwide, approximately 796,000 women may experience delay in diagnosis and/or treatment initiation. In an exploratory, scenario-based approximation, nearly 127,000 deaths each year could be associated with delay in diagnosis and/or treatment initiation due to more advanced disease presentation and postponed interventions. CONCLUSIONS AND RELEVANCE: These findings highlight the challenges women face in accessing mammography programs and the large number of women living in regions without mammography coverage (e.g., due to socioeconomic status or distance to a mammography center). They underscore the urgent need for the WHO Global Breast Cancer Initiative, which aims to establish early detection programs to promote earlier diagnosis and reduce BC mortality, especially in low- and middle-income countries.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-13
DOI
https://doi.org/10.1016/j.canep.2026.103257
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A systematic review of barriers to mammography screening and timely breast cancer diagnosis and treatment initiation: estimating the global impact.

Shani Paluch–Shimon, Kurt Neeser, Elvira Mueller, Melina Arnold et al.
PubMed
Global Cancer Incidence and Screening
article

A systematic review of barriers to mammography screening and timely breast cancer diagnosis and treatment initiation: estimating the global impact.

Shani Paluch–Shimon, Kurt Neeser, Elvira Mueller, Melina Arnold, Evandro de Azambuja, Pavel Napalkov, Carlos H Barrios
article en

Abstract

IMPORTANCE: Breast cancer (BC) is the most commonly diagnosed cancer among women and a leading cause of cancer mortality worldwide. Understanding and addressing the barriers women face in accessing BC care is crucial for improving clinical outcomes and public health. OBJECTIVE: This paper describes and discusses the findings from a systematic literature review (SLR) of the barriers that women worldwide face in accessing mammography screening and diagnosis, which may lead to delays in BC treatment. We also aimed to estimate the number of women worldwide affected by delayed or absent. We also aimed to estimate the number of women affected by delayed or absent access to medical services. EVIDENCE REVIEW: The systematic literature review included a comprehensive search in bibliographic databases and grey literature. A total of 20,434 citations were identified, with 2,611 citations eligible for full-text examination, which resulted in 256 extracted sources fulfilling the inclusion criteria. We focused on quantitative data on the number of patients whose access to BC-related medical services was hindered by such barriers. FINDINGS: The review identified education, age, and geographic region as important factors influencing barriers to mammography. Educational level, residential location, and travel time showed the strongest associations with delay in BC diagnosis. Socio-demographic characteristics also had an impact on the stage of cancer at diagnosis. An estimated 869.8 million women are aged 50-75 years worldwide. Of these, approximately 679.7 million women (78%) do not receive mammography because either their country has no established mammography program (557.7 million) or because existing programs have low uptake rates for various reasons (122.1 million). Of the 2.3 million new BC cases annually worldwide, approximately 796,000 women may experience delay in diagnosis and/or treatment initiation. In an exploratory, scenario-based approximation, nearly 127,000 deaths each year could be associated with delay in diagnosis and/or treatment initiation due to more advanced disease presentation and postponed interventions. CONCLUSIONS AND RELEVANCE: These findings highlight the challenges women face in accessing mammography programs and the large number of women living in regions without mammography coverage (e.g., due to socioeconomic status or distance to a mammography center). They underscore the urgent need for the WHO Global Breast Cancer Initiative, which aims to establish early detection programs to promote earlier diagnosis and reduce BC mortality, especially in low- and middle-income countries.

PubMedVol. 105
F. Hoffmann-La Roche AG (CH), Université Libre de Bruxelles (BE), Hebrew University of Jerusalem (IL), Hadassah Medical Center (IL), Institut Jules Bordet (BE), Eastern Cooperative Oncology Group (US)
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon